PT Duta Intidaya Tbk (IDX:DAYA)
Indonesia · Delayed Price · Currency is IDR 910.00
+30.00 (3.41%)
Aug 1, 2025, 3:49 PM WIB
Verve Therapeutics Cash Flow Statement
Financials in millions IDR. Fiscal year is January - December.
Millions IDR. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2016 - 2020 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '25 Mar 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2016 - 2020 |
Net Income | 52,651 | 45,675 | -16,189 | -40,024 | -51,709 | -48,817 | Upgrade |
Depreciation & Amortization | 157,190 | 123,198 | 124,888 | 130,655 | 119,777 | 109,999 | Upgrade |
Other Operating Activities | 11,017 | -73,531 | 177,233 | 43,829 | -93,124 | -25,692 | Upgrade |
Operating Cash Flow | 220,858 | 95,343 | 285,933 | 134,461 | -25,056 | 35,489 | Upgrade |
Operating Cash Flow Growth | 1.83% | -66.66% | 112.65% | - | - | -77.61% | Upgrade |
Capital Expenditures | -55,573 | -50,357 | -27,546 | -34,554 | -19,460 | -39,528 | Upgrade |
Sale of Property, Plant & Equipment | - | - | - | - | - | 28.85 | Upgrade |
Other Investing Activities | -52,739 | -45,209 | -7,815 | -6,041 | - | - | Upgrade |
Investing Cash Flow | -108,312 | -95,566 | -35,361 | -40,596 | -19,460 | -39,499 | Upgrade |
Short-Term Debt Issued | - | 613,000 | 28,000 | 10,000 | 126,000 | 70,000 | Upgrade |
Total Debt Issued | 805,000 | 613,000 | 28,000 | 10,000 | 126,000 | 70,000 | Upgrade |
Short-Term Debt Repaid | - | -521,000 | -141,000 | -25,000 | -25,000 | - | Upgrade |
Long-Term Debt Repaid | - | -67,942 | -87,402 | -62,072 | -57,403 | -42,935 | Upgrade |
Total Debt Repaid | -824,532 | -588,942 | -228,402 | -87,072 | -82,403 | -42,935 | Upgrade |
Net Debt Issued (Repaid) | -19,532 | 24,058 | -200,402 | -77,072 | 43,597 | 27,065 | Upgrade |
Other Financing Activities | -19,099 | -15,034 | -5,796 | -9,451 | -13,881 | -14,544 | Upgrade |
Financing Cash Flow | -38,630 | 9,023 | -206,198 | -86,523 | 29,716 | 12,521 | Upgrade |
Foreign Exchange Rate Adjustments | 24.49 | 24.92 | -8.64 | 186.51 | 12.17 | 8.19 | Upgrade |
Net Cash Flow | 73,941 | 8,825 | 44,365 | 7,529 | -14,788 | 8,520 | Upgrade |
Free Cash Flow | 165,286 | 44,985 | 258,386 | 99,907 | -44,516 | -4,038 | Upgrade |
Free Cash Flow Growth | -12.55% | -82.59% | 158.63% | - | - | - | Upgrade |
Free Cash Flow Margin | 7.27% | 2.18% | 16.71% | 8.60% | -4.58% | -0.46% | Upgrade |
Free Cash Flow Per Share | 68.28 | 18.59 | 106.75 | 41.27 | -18.39 | -1.67 | Upgrade |
Cash Interest Paid | 18,425 | 15,034 | 19,096 | 20,934 | 23,386 | 18,132 | Upgrade |
Cash Income Tax Paid | 8,093 | 11,292 | 3,040 | 6,692 | 7,634 | 473.9 | Upgrade |
Levered Free Cash Flow | 188,599 | 43,919 | 257,361 | 112,581 | -21,289 | 13,965 | Upgrade |
Unlevered Free Cash Flow | 201,038 | 54,200 | 265,958 | 126,295 | -4,277 | 25,586 | Upgrade |
Change in Net Working Capital | -27,161 | 81,761 | -160,948 | -36,109 | 100,913 | 30,115 | Upgrade |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.